Navigation Links
Senetek PLC Reports 2007 Financial Results
Date:4/15/2008

Investor Conference Call Scheduled for April 24

NAPA, Calif., April 15 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced results for the fourth quarter and year ended December 31, 2007.

Revenue for the year ended December 31, 2007 were $26,471,000, compared with $8,431,000 reported in 2006. Revenues for the fourth quarter of 2007 were $223,000, compared with $2,130,000 for the same period in the prior year.

Net income for the year ended December 31, 2007 totaled $18,632,000 or $2.41 per diluted share compared to $1,883,000 or $0.24 per diluted share in 2006. Net loss for the fourth quarter of 2007 was $1,706,000, or $0.22 per diluted share compared with net income of $575,000, or $0.08 per diluted share in the fourth quarter of 2006.

Cash flow from operations for the year ended December 31, 2007 increased to $18,019,000 compared with $1,290,000 in 2006.

The increase in 2007 revenues, net income and cash flow compared to 2006 is primarily attributable to the effect of the previously announced grant of a paid up license for Kinetin and Zeatin to Valeant Pharmaceuticals Inc. in March 2007 which contributed $24,750,000 to skincare revenues in the first quarter of 2007.

The decrease in 2007 fourth quarter revenues and net income compared to fourth quarter 2006 is primarily attributable to the elimination of Kinetin and Zeatin royalties after March 2007.

"We look forward to updating our shareholders on April 24th regarding our plans for the remainder of 2008," said Frank J. Massino, Senetek's Chairman and CEO.

The Company will conduct its quarterly teleconference call for investors on Thursday, April 24, 2008 at 9:00 a.m. Pacific, 12:00 p.m. Eastern to be hosted by Mr. Frank J. Massino, Chairman & CEO and Mr. William F. O'Kelly, Chief Financial Officer. The domestic
'/>"/>

SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
2. Senetek PLC Announces Launch of New Website
3. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Senetek PLC Reports Third Quarter 2007 Financial Results
5. Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
6. Exponent Reports First Quarter 2008 Results
7. J.D. Power and Associates Reports: HealthFusion Recognized for Providing an Outstanding Customer Service Experience
8. Marijuana use on the rise among Ontario adults, CAMH reports
9. Longs Reports Preliminary March Retail Drug Store Sales
10. CardioDynamics Reports 22% Revenue Growth in First Quarter 2008
11. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Pomona, NY (PRWEB) May 18, 2013 Dr. ... sleep apnea dentistry, employs his knowledge of the ... in sleep apnea patients. With May being Better Sleep Month, ... have some sort of chronic sleep disorder, and sleep apnea ... With sleep apnea, a person will essentially stop breathing at ...
(Date:5/18/2013)... May 18, 2013 John Ravera, D.D.S., a ... addition of a new member to his dental team, Courtney ... in the field for over 10 years. She received her ... and was elected a member of Sigma Pi Alpha, a ... Marino enjoys working with patients of all ages, helping them ...
(Date:5/18/2013)... 2013 According to the the Stevens Johnson ... Epidermal Necrolysis, is a severe allergic reaction usually to medicine ... but it can quickly advance causing blistering and large areas ... death. SJS can develop at any time and seriously ... NBA player, Manute Bol, passed away after he received kidney ...
(Date:5/18/2013)... The product liability attorneys at Wright & Schulte have ... nationwide who have sustained serious tendon injuries allegedly caused by ... all part of MDL 2308 and were all filed on ... heard in the U.S. District Court of the Western District ... specializes in defending the rights of those who have suffered ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Daily Gossip announced ... with the creator of the Program Yourself Thin ... on their online website by the end of the month ... accomplish to successfully reeducate themselves and lead a healthy lifestyle, ... Program Yourself Thin package is available for only $97 ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... its key inflammatory mediators (IL-12 and IL-23) is highly ... researchers. ,Current treatments for psoriasis include ... symptoms of the disease. Many of these treatments are ... very effective, according to Gerald Krueger, M.D., principal investigator ...
... extreme losses -- in two cases, greater than $100,000 -- ... been linked to a class of drugs commonly used to ... Mayo Clinic study is the first to describe this compulsive ... that stimulate dopamine receptors in the brain. ,The ...
... A botched up family planning operation would have claimed one ... of Indian origin// wasn't there to perform a lifesaving surgery. ... 300 km from here, was a boon for Vijayanti Devi, ... was cut out by mistake during a routine family planning ...
... set to start its manufacturing facility in the ... drug market. ,Ind-Swift Laboratories has completed ... its Clarithromycin active pharmaceutical ingredient (API) manufacturing unit, ... ,Clarithromycin is a macrolide antibiotic molecule ...
... diagnosis laboratories and counselling centres in various hospitals as HIV ... ,The decision was announced at the second meeting of the ... UNB reported. ,The meeting, chaired by health advisor ... policy, said a press release. ,The meeting decided ...
... of diseases or disorders of the valves in the heart ... caused by diseases such as rheumatic fever, or degenerative// conditions ... for valvular heart disease (VHD) highlight the need for improvement ... chair of the European Society of Cardiology (ESC) task force ...
Cached Medicine News:Health News:New Treatment For Psoriasis Is Highly Effective 2Health News:Medications for Restless Legs Syndrome may Trigger Compulsive Gambling 2Health News:Medications for Restless Legs Syndrome may Trigger Compulsive Gambling 3Health News:New Guidelines for VHD 2Health News:New Guidelines for VHD 3Health News:New Guidelines for VHD 4
(Date:5/17/2013)... -- Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) a ... patent-pending technologies poised to redefine how consumers receive energy, medicines, ... business update teleconference and webcast for shareholders and the investment ... PM ET. Fuse Science, Inc. CEO, ... will be joined by Rubin Hanan , ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)... BEIJING , May 17, 2013 Sinovac Biotech ... vaccines in China , today announced that ... quarter ended March 31, 2013, before market on Tuesday, May ... Tuesday, May 28, 2013, at 8:00 a.m. EDT (May 28, ... Company,s financial results and provide an update on recent corporate ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
... to be Dosed Shortly -, SAN DIEGO, March ... completion of the safety and,tolerability assessment of its third ... new HspE7 (HspE7 + Poly-ICLC) in patients with cervical,intraepithelial ... and met the limits prescribed in the trial protocol, ...
... will remain open until March 21, 2008, ... as,government agencies when implementing new policies, a national ... today,called for public comment on a series of ... trials., As part of the four year ...
Cached Medicine Technology:Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 5EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: